Insider Transactions in Q1 2021 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2021
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,067
-1.91%
|
$66,154
$62.37 P/Share
|
|
Jan 05
2021
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
288
-1.06%
|
$17,856
$62.37 P/Share
|
|
Jan 05
2021
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
772
-1.94%
|
$47,864
$62.37 P/Share
|
|
Jan 04
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
600
-23.89%
|
$36,000
$60.65 P/Share
|
|
Jan 04
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
600
+19.28%
|
$6,000
$10.85 P/Share
|
|
Jan 04
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
103,438
-15.81%
|
$6,206,280
$60.81 P/Share
|
|
Jan 04
2021
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
103,438
+16.9%
|
$1,758,446
$17.73 P/Share
|